CoagulationDisorders near Montvale, NJ

Biography: Dr. Marshall Posner, MD is a Hematology Specialist who practices in New York, NY. He is 76 years old and has been practicing for 50 years. Dr. Marshall Posner, MD is affiliated with Mount Sinai Hospital.

Care Philosophy: I am a medical oncologist with interests in lung cancers, head and neck cancers, and pancreatic cancers. Its important to me that patients feel they are not alone in their fight against cancer. I have a strong interest in clinical trial and providing patients with the most advanced available care. My goal is to help patients be in control with their health and understand their treatment options.

Biography: Dr. Keren Osman, MD is a Hematology Specialist who practices in New York, NY. She is 55 years old and has been practicing for 29 years. Dr. Keren Osman, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Jini Hyun is an Assistant Professor of Clinical Medicine at Weill Cornell Medicine and Attending Physician at New York-Presbyterian Queens (NYPQ). After obtaining her Masters of Science in Pharmacology and Pharmacognosy at the Seoul National University in 2001, Dr. Hyun performed research at the University of Illinois at Chicago before obtaining her medical degree from St. George's University in 2013.She was a rotating resident at the National Heart, Lung and Blood Institute in 2015. In 2017, Dr. Hyun completed an internal medicine residency at NewYork-Presbyterian Queens where she also served as Chief Resident. Following residency, Dr. Hyun completed her hematology and medical oncology fellowship training at SUNY Downstate Medical Center where she held the title of Chief Fellow. Dr. Hyun is part of the Hematology and Medical Oncology team at NYPQ and is accepting new patients.

Biography: Jones Nauseef, M.D., Ph.D., is an Assistant Professor of Medicine within the Division of Hematology and Medical Oncology at Weill Cornell Medicine, and Assistant Attending physician at NewYork-Presbyterian Hospital. His clinical emphasis is on Genitourinary (GU) cancers and Phase I clinical trials. His research is focused on genomics of advanced prostate cancers, including neuroendocrine prostate cancer, as well as health care disparities.Dr. Nauseef received his B.A. in Biology in 2006 from Swarthmore College, where he also participated in NCAA Track and Cross Country. In 2015, Dr. Nauseef earned his M.D. and Ph.D. in Molecular Physiology and Biophysics (Laboratory of Dr. Michael D. Henry) as part of the NIH-sponsored MedicalScientist Training Program (MSTP) at the Carver College of Medicine of theUniversity of Iowa. He continued his medical training at Weill Cornell Medicine and NewYork-Presbyterian (WCM/NYP), where he completed his Internship and Residency in Internal Medicine in 2018. He was honored to be the recipient of the David B. Skinner award at the conclusion of his residency. He remained at WCM/NYP for his Fellowship in Hematology and Medical Oncology, during which time he was awarded a 2020 Conquer Cancer Foundation of ASCO Young Investigator Award (YIA) and the 2021 Scott Wadler Fellows Clinical Research Award. During his Fellowship, Dr. Nauseef expanded his research focus to include the genomics of advanced prostate cancers and health care disparities in American men of African descent. He serves as co-investigator or collaborator on extramural grants for the latter project. Dr. Nauseef will continue these investigations as a member of the Englander Institute for Precision Medicine and inaffiliation with the New York Genome Center, with the primary goal of leveraging discoveries to develop clinical trials as part of the Phase I/Earlytherapeutics group at Weill Cornell's Meyer Cancer Center.

Biography: Dr. Sofya Pintova, MD is a Hematology Specialist who practices in New York, NY. She is 43 years old and has been practicing for 17 years. Dr. Sofya Pintova, MD is affiliated with Mount Sinai Morningside, Mount Sinai Brooklyn and Mount Sinai Hospital.

Biography: Prakash Satwani, MD specializes in the use of bone marrow transplantation to treat children and adolescents with leukemia, lymphoma, or hemophagocytic lymphohistiocytosis. Bone marrow transplantation is a dynamic, intriguing field with multiple complex issues. Dr. Satwani has always enjoyed solving puzzles and is attracted to the intellectual challenge of caring for patients whose lives may be saved or extended with bone marrow transplantation. Dr. Satwani is also inspired and motivated by the long-lasting and rich relationships formed with patients and their families, and often keeps in touch with families long after their child's treatment has been completed. Dr. Satwani teaches medical students, residents, fellows, nurses, and nurse practitioners about bone marrow transplantation. It's important to educate people so they can learn the latest advances and provide the best care possible for patients. To continue to achieve those advances, Dr. Satwani conducts clinical research in reducing the life-threatening complications related to transplantation, such as infections and graft-versus-host disease. Dr. Satwani and colleagues also evaluate reduced-intensity bone marrow transplantation preparative regimens, which use lower doses of chemotherapy with the hope of decreasing short-term and long-term complications without compromising the effectiveness of treatment.

Biography: Dr. S. Sunghyun Yoon is the Chief of the Division of Surgical Oncology and Vice-Chair of Surgical Oncology Research and Education in the Department of Surgery at Columbia University Irving Medical Center (CUIMC). Dr. Yoon is a national and international expert in the treatment of patients with sarcomas and other soft tissue tumors, gastric (stomach) and gastroesophageal cancers, gastrointestinal stromal tumors (GISTs), and melanoma. He also has over 18 years of experience in the treatment of other gastrointestinal and abdominal tumors, hepatobiliary tumors, neuroendocrine/adrenal tumors, lymphomas, and spleen tumors. He has been the principal investigator of several clinical trials examining novel treatment strategies and given numerous invited national and international lectures in relation to these cancers. Several of these trials have investigated the treatment of sarcomas, especially abdominal/retroperitoneal sarcomas, with advanced radiation techniques such as proton beam radiation and aggressive surgical resection to minimize local recurrence. Read More About These Treatments: https://columbiasurgery.org/conditions-and-treatments/retroperitoneal-sarcomas-and-pelvic-sarcomas Dr. Yoon was an early advocate for minimally invasive robotic surgery and has performed over 300 robotic procedures including robotic gastrectomies (stomach removal). He has one of the world's largest experiences in performing prophylactic total gastrectomies for patients with hereditary diffuse gastric cancer (HDGC syndrome) secondary to germline CDH1 mutation. He pioneered a technique for connection of the small bowel to the esophagus after total gastrectomy that is used by former surgical trainees and colleagues throughout the country due to its extremely low leakage rate. Dr. Yoon graduated from Harvard University and received his M.D. from the University of California at San Diego. He completed his residency in general surgery at Massachusetts General Hospital and his fellowship in surgical oncology at the Memorial Sloan-Kettering Cancer Center. He was an Associate Professor of Surgery at Massachusetts General Hospital and Harvard Medical School before joining the staff at Memorial Sloan-Kettering Cancer Center in 2012. Dr. Yoon was an Attending Surgeon in the Division of Gastric and Mixed Tumors at Memorial Sloan Kettering Cancer Center and a Professor of Surgery at Weill Cornell Medical College before joining CUIMC in 2021. Dr. Yoon's main research interests are in cancer stem cells and targeted biological agents in combination with chemotherapy and radiation therapy. His laboratory has been funded by the National Institutes of Health/National Cancer Institute for 18 years and strives to translate new research discoveries into the clinic. Dr. Yoon is also part of multi-institution research groups funded by Stand Up To Cancer and the DeGregorio Family Foundation to discover early diagnostics and new therapies for gastric cancer. His clinical and research efforts have led to over 150 original research articles, book chapters, and reviews. For a complete list of publications, please visit NCBI.